Yes, I do think we need non-glucocorticoid forms of therapy to treat 21-hydroxylase deficiency congenital adrenal hyperplasia. The most common form of congenital adrenal hyperplasia (CAH ...

the global Antibody Drug Conjugates (ADCs) Market is valued at USD 9.4 billion in 2024 and is projected to reach a value of USD 21.27 billion by 2035, at a CAGR of 7.75% between 2025 and 2035. The ...